Table 2.
Characteristic | Postoperative Complicationa
|
No Complicationa
|
||
---|---|---|---|---|
OR (95% CI) | P Value | OR (95% CI) | P Value | |
Open TAA Repair | ||||
| ||||
Early PCP follow-up | 0.53 (0.37–0.75) | <.001 | 0.97 (0.69–1.37) | .87 |
| ||||
Length of hospital stay, d | ||||
| ||||
<9 | 1 [Reference] | 1 [Reference] | ||
| ||||
≥9 | 1.16 (0.84–1.60) | .36 | 0.83 (0.62–1.11) | .20 |
| ||||
Age, y | ||||
| ||||
65–69 | 1 [Reference] | 1 [Reference] | ||
| ||||
70–79 | 1.06 (0.73–1.53) | .77 | 0.98 (0.70–1.36) | .88 |
| ||||
≥80 | 1.34 (0.81–2.23) | .25 | 0.98 (0.58–1.66) | .93 |
| ||||
Black race | 1.47 (0.62–3.51) | .39 | 1.40 (0.69–2.84) | .35 |
| ||||
Male sex | 1.10 (0.76–1.60) | .61 | 0.70 (0.53–0.93) | .01 |
| ||||
Charlson comorbidity index score | ||||
| ||||
<1 | 1 [Reference] | 1 [Reference] | ||
| ||||
1–2 | 1.41 (0.80–2.51) | .24 | 1.30 (0.72–2.02) | .34 |
| ||||
>2 | 1.62 (1.12–2.35) | .01 | 1.36 (0.84–2.57) | .23 |
| ||||
Open VHR | ||||
| ||||
Early PCP follow-up | 0.74 (0.52–1.06) | .10 | 1.05 (0.93–1.18) | .43 |
| ||||
Length of hospital stay, d | ||||
| ||||
<3 | 1 [Reference] | 1 [Reference] | ||
| ||||
≥3 | 1.08 (0.84–1.40) | .54 | 1.58 (1.46–1.71) | <.001 |
| ||||
Age, y | ||||
| ||||
65–69 | 1 [Reference] | 1 [Reference] | ||
| ||||
70–79 | 1.03 (0.81–1.31) | .80 | 0.99 (0.91–1.08) | .78 |
| ||||
≥80 | 1.05 (0.76–1.44) | .77 | 1.07 (0.96–1.19) | .22 |
| ||||
Black race | 1.61 (1.03–2.50) | .04 | 1.35 (1.14–1.60) | <.001 |
| ||||
Male sex | 1.15 (0.92–1.44) | .23 | 0.96 (0.87–1.03) | .27 |
| ||||
Charlson comorbidity index score | ||||
| ||||
<1 | 1 [Reference] | 1 [Reference] | ||
| ||||
1–2 | 1.23 (0.97–1.54) | .08 | 1.32 (1.21–1.44) | <.001 |
| ||||
>2 | 1.28 (0.90–1.81) | .16 | 1.68 (1.50–1.89) | <.001 |
Abbreviations: OR, odds ratio; PCP, primary care provider; TAA, thoracic aortic aneurysm; VHR, ventral hernia repair.
Includes major postoperative complications such as renal failure, pulmonary failure, spinal cord ischemia, cerebrovascular event, and gastrointestinal injury or ischemia for patients undergoing open TAA repair; and bowel injury, cardiopulmonary failure, and accidental laceration for patients undergoing VHR.